help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.
Right arrow Articles by Shechter, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.
Right arrow Articles by Shechter, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MOLYBDENUM
*TUNGSTEN COMPOUNDS
Endocrinology Vol. 138, No. 6 2274-2279
Copyright © 1997 by The Endocrine Society


ARTICLES

Antilipolytic Actions of Vanadate and Insulin in Rat Adipocytes Mediated by Distinctly Different Mechanisms1

Jinping Li, Gerard Elberg2, Natesampillai Sekar, Zhi Bin He and Yoram Shechter3

Department of Biochemistry, The Weizmann Institute of Science, Rehovot 76100, Israel

Address all correspondence and requests for reprints to: Dr. Yoram Shechter, The Weizman Institute of Science, Department of Biochemistry, 76100 Rehovot, Israel.

Vanadate, which mimics the biological effects of insulin, also inhibits lipolysis in rat adipocytes. Here we demonstrate that the antilipolytic effect of vanadate differs from that of insulin at least by the five following criteria: 1) vanadate inhibits lipolysis mediated by high (supraphysiological) concentrations of catecholamines; 2) vanadate antagonizes (Bu)2cAMP-mediated lipolysis; 3) vanadate antagonizes isobutylmethylxanthine-dependent lipolysis, 4) vanadate inhibits lipolysis mediated by okadaic acid; and 5) wortmannin, which blocks the antilipolytic effect of insulin, fails to block vanadate-mediated antilipolysis. Vanadate does activate phosphoinositol 3-kinase, and wortmannin blocks this activation.

Our working hypothesis assumes that all of the insulin-like effects of vanadate, including antilipolysis, are initiated by the inhibition of protein phosphotyrosine phosphatases (PTPases). Among documented PTPase inhibitors we found that VOSO4 (oxidation state +4), several organic vanadyl compounds (+4), zinc (Zn2+), tungstate (W), and molybdate (Mo) also had antilipolytic activity. The order of potency was vanadyl acetylacetonate >= VOSO4 >= NaVO3 >= vanadyl-dipicolinate > Zn2+ W > Mo, and it correlated better with the inhibition of adipose membranal-PTPases in cell-free experiments. We have concluded that the antilipolytic effect of vanadate is 1) mechanistically distinct from that of insulin, 2) independent of phosphoinositol 3-kinase activation, and 3) independent of the lipolytic cascade. We also strongly suggest that the antilipolytic effect of vanadate emanates from inhibiting adipose membranal, rather than cytosolic PTPases, and present preliminary data showing distinct differences in catalysis between these two PTPase categories. Overall, the study indicates that antilipolysis can be manifested via alternative, insulin-independent, signal-transducing pathways.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. E. Waltner-Law, X. L. Wang, B. K. Law, R. K. Hall, M. Nawano, and D. K. Granner
Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production
J. Biol. Chem., September 13, 2002; 277(38): 34933 - 34940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. G. Cammisotto and L. J. Bukowiecki
Mechanisms of leptin secretion from white adipocytes
Am J Physiol Cell Physiol, July 1, 2002; 283(1): C244 - C250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. J. Lynch, B. J. Patson, S. A. Goodman, D. Trapolsi, and S. R. Kimball
Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR
Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E25 - E34.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. Sun, N. Sekar, I. Goldwaser, E. Gershonov, M. Fridkin, and Y. Shechter
Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism
Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E403 - E410.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Goldwaser, J. Li, E. Gershonov, M. Armoni, E. Karnieli, M. Fridkin, and Y. Shechter
L-Glutamic Acid gamma -Monohydroxamate. A POTENTIATOR OF VANADIUM-EVOKED GLUCOSE METABOLISM IN VITRO AND IN VIVO
J. Biol. Chem., September 10, 1999; 274(37): 26617 - 26624.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Sekar, J. Li, Z. He, D. Gefel, and Y. Shechter
Independent Signal-Transduction Pathways for Vanadate and for Insulin in the Activation of Glycogen Synthase and Glycogenesis in Rat Adipocytes
Endocrinology, March 1, 1999; 140(3): 1125 - 1131.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. Sekar, S. Qian, and Y. Shechter
Vanadate Elevates Lipogenicity of Starved Rat Adipose Tissue: Mechanism of Action
Endocrinology, May 1, 1998; 139(5): 2514 - 2518.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society